Biomarkers are often used during the management of cancer to guide treatment decisions and predict patient outcomes. However, it is often difficult to identify appropriate biomarkers […]
The characteristics of acceptable preapproval evidence were more flexible for novel drugs approved by the U.S. Food and Drug Administration in 2020, according to a research […]
Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.
Pfizer’s anti-COVID pill Paxlovid is helping stave off hospitalizations and deaths amid the United States’ latest wave of infections, a senior White House official said Wednesday.